Valuable Resources for:

Patients, Families and Friends

Liver Diseases and Related Topics

Select Info CenterAlagille SyndromeAlcohol-Induced Liver DiseaseAlpha-1 Antitrypsin DeficiencyAutoimmune HepatitisBenign Liver TumorsBiliary Atresia (BA)CirrhosisFatty LiverGalactosemiaHemochromatosisHepatitis AHepatitis BHepatitis CLiver CancerLiver TransplantPrimary Biliary Cirrhosis (PBC)Primary Sclerosing Cholangitis (PSC)Reye SyndromeThe Progression of Liver DiseaseType I Glycogen Storage DiseaseWilson Disease

Find the Chapter Nearest You

Select your State/RegionAlabamaAlaskaArizonaArkansasCalifornia (Los Angeles)California (Northern California)California (San Diego)ColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontana (East)Montana (West)NebraskaNevadaNew HampshireNew Jersey (Central and South)New Jersey (North)New MexicoNew YorkNew York (Upstate)North CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPennsylvania (Western)Rhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming

Voices of Liver Disease

When country music star Naomi Judd was stuck by a needle as a young nurse, she contracted hepatitis C. Her music career ended when her battle against hepatitis began.

This Is Her Story

Help Fight Liver Disease

Please Donate
Your gifts are crucial to fight liver disease. Please give today.

Please Volunteer
Help our chapters in the fight against liver disease. Please volunteer today.

Liver Disease News

A news summary from around the world about the fight against liver diseases.

BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients
Posted on April 26th 2008
Bristol-Myers Squibb Company announced new data from the E.A.R.L.Y. study, in which treatment of antiviral-naive adult chronic hepatitis B patients with Baraclude (entecavir) resulted in greater long-term viral load reduction than adefovir at 96 weeks - consistent with earlier 12-week results (primary endpoint). These data were presented last week in Milan, Italy, at the 43rd Annual Meeting of the European Association for the Study of the Liver.

Vertex reports promising hepatitis C drug results
Posted on April 24th 2008
Vertex Pharmaceuticals Inc. on Wednesday said early trial results show that its experimental hepatitis C treatment controlled or eradicated the virus in more than 80 percent of patients for whom previous treatment had failed. The trial results were presented in Milan at a meeting of the European Association for the Study of the Liver.

Sugarland, Nominated for 2008 CMT Awards, Names American Liver Foundation Charity of Choice
Posted on March 28th 2008
CMT will gift $2500 to charities of winners in each category. Your Vote for Sugarland is a Vote for the American Liver Foundation

See all of our news items

Events

view all

Flavors Culinary Galas
Experience the tastes of our signature Flavors events nationwide.

Outdoor Events
Run, walk, or climb to support ALF! Join us June 7-8 at
The Climb for Research

Educational Events

15th International Symposium on Hepatitis C and Related Viruses, Oct. 5-9

ALF is the nation's leading nonprofit organization promoting liver disease prevention and liver wellness. ALF provides research, education and advocacy for those affected by liver-related diseases, including hepatitis.

© Copyright 2008 American Liver Foundation. All Rights Reserved.